oral semaglutide cardiovascular outcomes soul trial results 2024 2025 soul trial oral semaglutide cardiovascular outcomes results 2024 2025 Oral Semaglutide and Cardiovascular Outcomes in People Semaglutide reduces heart failure risk

Most gastrointestinal symptoms improve within 24 weeks as the body adapts, but serious adverse events including pancreatitis, gallbladder issues, and thyroid concerns require immediate medical attention and ongoing monitoring

1,2,3 The caveat is that were comparing trials that werent designed to be compared

Recognizing its potent effects on weight reduction, Eli Lilly pursued a separate indication for chronic weight management

Skip and resume the next day

Related Reading Spirulina for Weight Loss: What 12 Studies Actually Show 12 clinical studies on spirulina and weight management, including the GLP-1 mechanism